Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis
Publication details: 2020Description: 674-681ISSN:- 02694727
- Journal of Clinical Pharmacy and Therapeutics
No physical items for this record
There are no comments on this title.
Log in to your account to post a comment.